X
CVS icon

Xponance’s CVS Health CVS Stock Holding History

Xponance’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Buy
263,078
+31,106
+13% +$2.78M 0.17% 88
2026
Q1 		$16.7M Buy
231,972
+31,447
+16% +$2.42M 0.12% 141
2025
Q4 		$15.9M Buy
200,525
+11,046
+6% +$871K 0.12% 132
2025
Q3 		$14.3M Sell
189,479
-3,683
-2% -$252K 0.11% 141
2025
Q2 		$13.3M Buy
193,162
+4,654
+2% +$305K 0.11% 151
2025
Q1 		$12.8M Sell
188,508
-326
-0.2% -$19.5K 0.12% 141
2024
Q4 		$8.48M Buy
188,834
+4,585
+2% +$257K 0.08% 200
2024
Q3 		$11.6M Buy
184,249
+3,666
+2% +$214K 0.11% 145
2024
Q2 		$10.7M Sell
180,583
-7,245
-4% -$453K 0.11% 139
2024
Q1 		$15M Buy
187,828
+12,864
+7% +$983K 0.16% 114
2023
Q4 		$13.8M Sell
174,964
-1,088
-0.6% -$77.4K 0.17% 105
2023
Q3 		$12.3M Buy
176,052
+4,599
+3% +$326K 0.17% 102
2023
Q2 		$11.9M Buy
171,453
+176
+0.1% +$12.5K 0.16% 108
2023
Q1 		$12.7M Sell
171,277
-2,017
-1% -$169K 0.19% 103
2022
Q4 		$16.1M Buy
173,294
+30,926
+22% +$2.98M 0.26% 76
2022
Q3 		$13.6M Buy
142,368
+22,203
+18% +$2.2M 0.26% 74
2022
Q2 		$11.1M Buy
120,165
+786
+0.7% +$76.7K 0.22% 78
2022
Q1 		$12.1M Buy
119,379
+3,826
+3% +$402K 0.2% 84
2021
Q4 		$11.9M Buy
115,553
+21,494
+23% +$1.99M 0.19% 94
2021
Q3 		$7.98M Sell
94,059
-42,189
-31% -$3.53M 0.15% 121
2021
Q2 		$11.4M Sell
136,248
-5,390
-4% -$441K 0.21% 83
2021
Q1 		$10.7M Buy
141,638
+77
+0.1% +$5.61K 0.23% 82
2020
Q4 		$9.67M Sell
141,561
-46
-0% -$2.99K 0.21% 85
2020
Q3 		$8.27M Sell
141,607
-19,838
-12% -$1.23M 0.2% 98
2020
Q2 		$10.5M Buy
+161,445
New +$10.2M 0.27% 73

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Xponance's CVS Position: Q2 2026 in Review

Xponance increased its CVS Health (CVS) stake by 13% in Q2 2026, buying an estimated $2.78M and bringing the position to 263,078 shares worth $27.2M. The position accounts for 0.17% of the portfolio, ranked #88.

Xponance first reported a position in CVS in Q2 2020 and has held it in 25 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Xponance held 263,078 shares of CVS Health worth $27.2M as of Q2 2026.
  • Xponance bought 31,106 CVS Health shares in Q2 2026, an estimated $2.78M.
  • CVS Health made up 0.17% of Xponance's portfolio in Q2 2026, its #88 holding.
  • Xponance first reported a position in CVS Health in Q2 2020 and has held it in 25 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.